Method of preventing or reducing adverse reactions to protamine using a thromboxane A.sub.2 receptor antagonist

摘要

A method is provided for preventing reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A.sub.2 receptor antagonist.